These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1680784)

  • 1. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis.
    Woods AL; Hall PA; Shepherd NA; Hanby AM; Waseem NH; Lane DP; Levison DA
    Histopathology; 1991 Jul; 19(1):21-7. PubMed ID: 1680784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma.
    Visakorpi T
    J Pathol; 1992 Sep; 168(1):7-13. PubMed ID: 1360498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
    He W; Meyer JS; Scrivner DL; Koehm S; Hughes J
    Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis. A. L. Woods, P. A. Hall, N. A. Shepherd, A. M. Hanby, N. H. Waseem, D. P. Lane & D. A. Levison. Histopathology 1991; 19; 21-27.
    Levison DA
    Histopathology; 2002 Sep; 41(3A):162-3, discussion 163-4. PubMed ID: 12405948
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10.
    Wilson GD; Camplejohn RS; Martindale CA; Brock A; Lane DP; Barnes DM
    Eur J Cancer; 1992; 28A(12):2010-7. PubMed ID: 1358156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
    Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
    Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen and S phase fraction in endometrial stromal sarcoma.
    Schofield JB; Mansi J; Camplejohn RS; Lane DP; Fisher C
    J Clin Pathol; 1992 Aug; 45(8):664-7. PubMed ID: 1357005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
    Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
    Krauss JS; Pantazis CG; Chandler FW
    Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PC10 monoclonal antibody to proliferating cell nuclear antigen as probe for cycling cell detection in developing tissues. A combined immunocytochemical and flow cytometric study.
    Casasco A; Giordano M; Danova M; Casasco M; Icaro Cornaglia A; Calligaro A
    Histochemistry; 1993 Mar; 99(3):191-9. PubMed ID: 7684034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma.
    Gillett CE; Barnes DM; Camplejohn RS
    J Clin Pathol; 1993 Dec; 46(12):1126-8. PubMed ID: 7904274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.
    Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W
    Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
    Thomas H; Nasim MM; Sarraf CE; Alison MR; Love S; Lambert HE; Price P
    Br J Cancer; 1995 Feb; 71(2):357-62. PubMed ID: 7841053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity.
    Gelb AB; Kamel OW; LeBrun DP; Warnke RA
    Am J Pathol; 1992 Dec; 141(6):1453-8. PubMed ID: 1281622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors.
    Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ
    Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating cell nuclear antigen immunolocalization in gastro-intestinal epithelia.
    Sarraf CE; McCormick CS; Brown GR; Price YE; Hall PA; Lane DP; Alison MR
    Digestion; 1991; 50(2):85-91. PubMed ID: 1687136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.
    Fontanini G; Macchiarini P; Pepe S; Ruggiero A; Hardin M; Bigini D; Vignati S; Pingitore R; Angeletti CA
    Cancer; 1992 Sep; 70(6):1520-7. PubMed ID: 1355398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.